Endothelial dysfunction in COVID-19: lessons learned from coronaviruses E Gavriilaki, P Anyfanti, M Gavriilaki, A Lazaridis, S Douma, ... Current hypertension reports 22, 1-12, 2020 | 155 | 2020 |
Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: a systematic review and meta‐analysis M Gavriilaki, P Anyfanti, B Nikolaidou, A Lazaridis, E Gavriilaki, S Douma, ... The Journal of Clinical Hypertension 22 (11), 1951-1959, 2020 | 45 | 2020 |
The impact of antibiotic-mediated modification of the intestinal microbiome on outcomes of allogeneic hematopoietic cell transplantation: systematic review and meta-analysis M Gavriilaki, I Sakellari, A Anagnostopoulos, E Gavriilaki Biology of Blood and Marrow Transplantation 26 (9), 1738-1746, 2020 | 32 | 2020 |
A new era in endothelial injury syndromes: toxicity of CAR-T cells and the role of immunity E Gavriilaki, I Sakellari, M Gavriilaki, A Anagnostopoulos International Journal of Molecular Sciences 21 (11), 3886, 2020 | 29 | 2020 |
An update in drug-induced thrombotic microangiopathy T Chatzikonstantinou, M Gavriilaki, A Anagnostopoulos, E Gavriilaki Frontiers in Medicine 7, 212, 2020 | 27 | 2020 |
Nusinersen in adults with 5q spinal muscular atrophy: a systematic review and meta-analysis M Gavriilaki, M Moschou, V Papaliagkas, K Notas, E Chatzikyriakou, ... Neurotherapeutics 19 (2), 464-475, 2022 | 25 | 2022 |
Autologous hematopoietic cell transplantation in multiple sclerosis: changing paradigms in the era of novel agents M Gavriilaki, I Sakellari, E Gavriilaki, VK Kimiskidis, A Anagnostopoulos Stem Cells International 2019 (1), 5840286, 2019 | 23 | 2019 |
Precision medicine in neurology: the inspirational paradigm of complement therapeutics M Gavriilaki, VK Kimiskidis, E Gavriilaki Pharmaceuticals 13 (11), 341, 2020 | 21 | 2020 |
Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: a systematic review N Stalikas, I Doundoulakis, E Karagiannidis, A Kartas, M Gavriilaki, ... European Journal of Internal Medicine 99, 38-44, 2022 | 19 | 2022 |
Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality I Sakellari, E Gavriilaki, S Papagiannopoulos, M Gavriilaki, I Batsis, ... Journal of Neurology 266, 1960-1972, 2019 | 19 | 2019 |
Endothelial dysfunction in psoriasis: an updated review P Anyfanti, A Margouta, K Goulas, M Gavriilaki, E Lazaridou, A Patsatsi, ... Frontiers in Medicine 9, 864185, 2022 | 17 | 2022 |
Isolated extramedullary relapse as a poor predictor of survival after allogeneic hematopoietic cell transplantation for acute leukemia I Sakellari, E Gavriilaki, I Batsis, D Mallouri, M Gavriilaki, C Apostolou, ... Biology of Blood and Marrow Transplantation 25 (9), 1756-1760, 2019 | 17 | 2019 |
Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysis M Gavriilaki, M Moschou, V Papaliagkas, K Notas, E Chatzikyriakou, ... Neuromuscular Disorders 32 (3), 185-194, 2022 | 15 | 2022 |
Neurologic complications after allogeneic transplantation: a meta‐analysis M Gavriilaki, M Mainou, E Gavriilaki, AB Haidich, S Papagiannopoulos, ... Annals of Clinical and Translational Neurology 6 (10), 2037-2047, 2019 | 14 | 2019 |
Association between ambulatory blood pressure monitoring patterns with cognitive function and risk of dementia: a systematic review and meta-analysis M Gavriilaki, P Anyfanti, K Mastrogiannis, E Gavriilaki, A Lazaridis, ... Aging Clinical and Experimental Research 35 (4), 745-761, 2023 | 9 | 2023 |
Atrial high-rate episodes in patients with devices without a history of atrial fibrillation: a systematic review and meta-analysis I Doundoulakis, M Gavriilaki, D Tsiachris, P Arsenos, CK Antoniou, ... Cardiovascular Drugs and Therapy 36 (5), 951-958, 2022 | 9 | 2022 |
Intrathecal administration of nusinersen using the ommaya reservoir in an adult with 5q-related spinal muscular atrophy type 1 and severe spinal deformity V Papaliagkas, N Foroglou, P Toulios, M Moschou, M Gavriilaki, K Notas, ... Case Reports in Neurology 13 (3), 710-715, 2022 | 9 | 2022 |
Biomarkers of therapeutic efficacy in adolescents and adults with 5q spinal muscular atrophy: a systematic review M Gavriilaki, V Papaliagkas, A Stamperna, M Moschou, K Notas, ... Acta Neurologica Belgica 123 (5), 1735-1745, 2023 | 7 | 2023 |
Thrombocytopenia in COVID-19: pathophysiology matters E Gavriilaki, I Sakellari, M Gavriilaki, A Anagnostopoulos Annals of Hematology 100, 2139-2140, 2021 | 7 | 2021 |
COVID-19 pandemic impact on neurologic emergencies: a single-center retrospective cohort study M Gavriilaki, E Karlafti, M Moschou, K Notas, M Arnaoutoglou, G Kaiafa, ... Pan African Medical Journal 41 (1), 2022 | 5 | 2022 |